| Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis JG Castellanos, V Woo, M Viladomiu, G Putzel, S Lima, GE Diehl, ... Immunity 49 (6), 1077-1089. e5, 2018 | 124 | 2018 |
| Leveraging phenotypic variability to identify genetic interactions in human phenotypes AR Marderstein, ER Davenport, S Kulm, CV Van Hout, O Elemento, ... The American Journal of Human Genetics 108 (1), 49-67, 2021 | 58 | 2021 |
| Pan-cancer analysis reveals molecular patterns associated with age Y Shah, A Verma, AR Marderstein, J White, B Bhinder, JSG Medina, ... Cell reports 37 (10), 2021 | 38 | 2021 |
| Demographic and genetic factors influence the abundance of infiltrating immune cells in human tissues AR Marderstein, M Uppal, A Verma, B Bhinder, Z Tayyebi, J Mezey, ... Nature communications 11 (1), 2213, 2020 | 30 | 2020 |
| A systematic framework for assessing the clinical impact of polygenic risk scores S Kulm, A Marderstein, J Mezey, O Elemento MedRxiv, 2020.04. 06.20055574, 2020 | 19 | 2020 |
| A polygenic-score-based approach for identification of gene-drug interactions stratifying breast cancer risk AR Marderstein, S Kulm, C Peng, R Tamimi, AG Clark, O Elemento The American Journal of Human Genetics 108 (9), 1752-1764, 2021 | 9 | 2021 |
| Pan-cancer analysis reveals unique molecular patterns associated with age Y Shah, A Verma, A Marderstein, B Bhinder, O Elemento medRxiv, 2020.08. 30.20184762, 2020 | 3 | 2020 |
| Integrated single-cell multiome analysis reveals muscle fiber-type gene regulatory circuitry modulated by endurance exercise AB Rubenstein, GR Smith, Z Zhang, X Chen, TL Chambers, ... bioRxiv, 2023 | 2 | 2023 |
| The gut microbiome regulates efficacy of sulfasalazine therapy for spondyloarthritis in inflammatory bowel disease S Lima, A Rupert, W Jin, M Viladomiu, S Pires, V Woo, G Putzel, ... Gastroenterology 164 (4), S93, 2023 | 1 | 2023 |
| The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis SF Lima, S Pires, A Rupert, S Oguntunmibi, WB Jin, A Marderstein, ... Cell Reports Medicine 5 (3), 2024 | | 2024 |
| The Impact of Genomic Variation on Function (IGVF) Consortium I Consortium arXiv preprint arXiv:2307.13708, 2023 | | 2023 |
| Single-cell multi-omics map of human foetal blood in Down's Syndrome AR Marderstein, M De Zuani, H Xue, J Bezney, S Wong, THH Coorens, ... bioRxiv, 2023.09. 25.559431, 2023 | | 2023 |
| DEFINING THE ROLE FOR THE GUT MICROBIOME IN THE CLINICAL EFFICACY OF SULFASALAZINE THERAPY FOR IBD ASSOCIATED SPONDYLOARTHRITIS SF Lima, A Rupert, M Viladomiu, A Marderstein, S Pires, G Putzel, V Woo, ... The Journal of Immunology 208 (1_Supplement), 174.01-174.01, 2022 | | 2022 |
| A polygenic score-based approach to identify gene-drug interactions stratifying breast cancer risk AR Marderstein, S Kulm, C Peng, R Tamimi, AG Clark, O Elemento medRxiv, 2021.05. 03.21256511, 2021 | | 2021 |
| Analyzing Modifiable Risk Factors in Disease Using Human Genetic Variation AR Marderstein Weill Medical College of Cornell University, 2021 | | 2021 |
| Transferable Immune Reactive Microbiota Determine Clinical and Immunologic Outcome of FMT in UC SF Lima, L Gogokhia, M Viladomiu, V Woo, A Marderstein, G Putzel, ... The Journal of Immunology 204 (1_Supplement), 237.14-237.14, 2020 | | 2020 |
| Defining the role for the gut microbiome in the clinical efficacy of sulfasalazine therapy for IBD associated spondyloarthritis SF Lima, R Longman, A Rupert, M Viladomiu, A Marderstein, G Putzel, ... The Journal of Immunology 204 (1_Supplement), 237.8-237.8, 2020 | | 2020 |
